Laboratoire d'Immunologie Moléculaire, Département de Microbiologie et Immunologie, Faculté de Médecine, Université de Montréal, Canada, H3C 3J7
* Author for correspondence (e-mail: jacques.thibodeau{at}umontreal.ca)
Accepted 19 July 2005
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: HLA, Iip35, RXR, Di-arginine, Antigen presentation
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The human gene encoding the invariant chain produces two separate mRNAs that differ by an alternatively spliced exon. Furthermore, the alternative use of two in-phase start codons on each mRNA produce either the major p33 and p35 or the minor p41 and p43 isoforms (Strubin et al., 1986; O'Sullivan et al., 1987
). Iip35 differs from p33 by an N-terminal cytoplasmic extension of 16 amino acids containing a strong di-arginine (RXR) ER retention motif (Schutze et al., 1994
). This signal plays a crucial role in the proper ER localization of many transmembrane proteins and regulates the association of multimeric protein complexes (Jackson et al., 1990
; Pelham, 1995
). By virtue of a COPI-mediated retrograde transport mechanism, the RXR motif usually mediates retrieval of unassembled subunits from post-ER compartments of the exocytic pathway (Cosson and Letourneur, 1994
; Zerangue et al., 1999
; Margeta-Mitrovic et al., 2000
; Bichet et al., 2000
; Standley et al., 2000
; O'Kelly et al., 2002
; Yuan et al., 2003
). Compared with their p35 counterpart, Iip33 homotrimers are sorted to the endocytic pathway in the absence of class-II molecules (Lamb and Cresswell, 1992
; Bakke and Dobberstein, 1990
; Teyton et al., 1990
). Accordingly, mixed trimers consisting of p33 and at least one p35 molecule accumulate in the ER (Lamb and Cresswell, 1992
; Marks et al., 1990
). In the presence of class-II molecules, the RXR motif of Iip35 is inactivated (Marks et al., 1990
). Still, the intracellular route to the endosomes presumably differs between p35-including nonamers and (
ßIip33)3, because the former complexes are not detected at the cell surface (Warmerdam et al., 1996
). In normal B cells, the proportion of the Ii pool bearing this ER retention signal has been estimated to be 20% (Anderson et al., 1999
). Therefore, Iip35 would play an important role in coordinating the assembly and transport of newly synthesized Ii and class-II molecules.
It has been reported that a serine residue (S8) present exclusively in the p35 cytoplasmic tail is phosphorylated in B-cell lines and transfected HeLa cells (Anderson et al., 1999; Anderson and Roche, 1998
; Kuwana et al., 1998
). Although the exact trafficking step requiring such phosphorylation is still a matter of debate, it is clearly a prerequisite for ER egress and efficient sorting of p35/class-II complexes to the endocytic pathway (Anderson et al., 1999
; Anderson and Roche, 1998
; Kuwana et al., 1998
).
Recently, O'Kelly and co-workers suggested that the binding of 14-3-3 and ßCOP is mutually exclusive on Iip35 (O'Kelly et al., 2002). The 14-3-3 family members are highly acidic dimeric cytoplasmic proteins that bind to phosphoserine motifs (Muslin and Xing, 2000
; Schutze et al., 1994
; Tzivion et al., 2001
; van Hemert et al., 2001
; Yaffe, 2002
). It was concluded that the 14-3-3 binding site constitutes a `release' motif allowing ER egress. However, this model does not take into account the fact that, even when associated with a 14-3-3 protein, Iip35 will not leave the ER in the absence of class-II molecules (Marks et al., 1990
; Kuwana et al., 1998
; Khalil et al., 2003
).
As a first step in characterizing the peculiar intracellular trafficking of Iip35, we have recently shown that the cytoplasmic tail of the class II ß chain is crucial for overcoming the ER-retention motif (Khalil et al., 2003). Our results demonstrated that a tailless DR molecule is expressed at the plasma membrane of transfected cells only in the absence of Iip35. Accordingly, Iip35 leaves the ER and is sorted to the endocytic pathway only when co-transfected with class-II molecules presenting a wild-type ß chain. Here, we refined the mapping of the important structural determinant and conclude that a three-amino-acid cytoplasmic ß tail is sufficient to allow full egress of Iip35.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell lines and transfections
MHC-class-II-negative HEK 293T (a kind gift from E. Cohen, University of Montreal, Quebec, Canada) and HeLa (ATCC CCL-2) cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Wisent, St-Bruno, Quebec, Canada) containing 10% foetal bovine serum (FBS; Wisent). For transient expression in HEK 293T, cells were co-transfected by the calcium-phosphate-precipitation method using 2 µg each DNA (Brunet et al., 2000). Cells were analysed 2-3 days after transfection. Stable transfection of the mutated class-II molecules in HeLa cells was performed using Fugene6 (Roche). Cells resistant to 100 µg ml1 ZeocinTM (Cayla, Toulouse, France) and expressing class-II
ß heterodimers were sorted using the L243 monoclonal antibody (mAb) coupled to magnetic beads (Dynal, New York, NY, USA). The Iip35 LI/ML cDNA was then transfected using Fugene6 and selected in 50 U ml1 hygromycin (Cederlane, Hornby, BC, Canada).
Antibodies
BU45 (IgG1) is a mAb specific to the C-terminal portion of the human Ii (Wraight et al., 1990). ISCR3, a kind gift from R. Busch (Stanford University, CA), recognizes the
ß heterodimer through an epitope on the DR
chain (Watanabe et al., 1983
). Goat anti-mouse antibody coupled to Alexa Fluor® 488 was obtained from Molecular Probes (Eugene, OR, USA).
Flow cytometry
For surface staining of Ii, cells were stained using Bu45 followed by a goat anti-mouse IgG coupled to Alexa Fluor 488. Intracellular staining for class-II molecules or Ii was done on saponin-permeabilized cells as previously described (Brunet et al., 2000; Khalil et al., 2003
). Briefly, cells were washed, fixed in 4% paraformaldehyde, permeabilized with saponin (Brunet et al., 2000
) and stained for Ii or class-II molecules using BU45 or ISCR3, respectively. Cells were analysed on a FACScalibur® flow cytometer (Becton Dickinson, Mississauga, ON, Canada).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Ability of the DRß cytoplasmic region to overcome the RXR motif of Iip35 is sequence independent
Fig. 2 shows a sequence alignment of the class-II ß chain cytoplasmic sequences that have been shown so far to overcome ER retention of Ii. A single amino acid (R232) is conserved between all these tails. To verify the importance of this residue and definitely to rule out the need for a specific more-C-terminal sequence, we performed an alanine scan on this region (Fig. 3). Mutant DRß chains were expressed transiently in HEK 293T cells together with the truncated DR chain and Iip35 LI/ML. Class-II levels were comparable and based on the ratio of surface to total invariant chain expression, we conclude that all mutants were able to overcome the RXR motif. Even the R232A mutation allowed ER egress and cell-surface expression of Iip35 LI-ML.
|
|
Three cytoplasmic DRß amino acids are sufficient to overcome retention
We next investigated the minimal requirements, in terms of length, for the HLA-DRß cytoplasmic tail to overcome the Ii retention motif. Stop codons were introduced by site-directed mutagenesis at various positions in the C-terminal coding region of DRß. First, the non-potent ßTM tail was extended by one or two amino acids to generate ßYF and ßYFR (Fig. 4A). These DRß chains were transiently expressed in HEK 293T cells together with the DRTM and Iip35 LI/ML. The ratios of surface to total Ii demonstrate that, whereas the truncated ßYF molecule does not allow ER egress of Ii, extending the DRß chain by only one additional residue (ßYFR) is sufficient fully to overcome the RXR retention motif. Interestingly, substitution of the Phe and Arg residues for alanines (ßYAA) also allowed egress of Iip35. However, in accordance with the results presented above, we found that a cytoplasmic tail extension of only one residue beyond the transmembrane-lining tyrosine (ßYA) is not sufficient to overcome ER retention. The capacity of the ßYFR and ßYAA tails to chaperone Iip35 out of the ER was confirmed in stably transfected HeLa cells (Fig. 4B). Altogether, these results demonstrate that a three-amino-acid cytoplasmic tail is sufficient to overcome the Iip35 RXR motif.
|
Replacing Tyr230 with Arg partially restores function
Given the role of the membrane-proximal residues in the capacity to overcome the Ii-retention motif, we investigated the importance of Tyr230 at the junction between the transmembrane and cytoplasmic regions of DRß. Tyrosine residues delimiting transmembrane domains usually span the interfacial region of the phospholipid bilayer and are not fully exposed in the cytoplasm (Bowie, 2005). We generated a truncated mutant DRß chain with a positively charged C-terminal Arg230 (DRß R) (Fig. 5). When this mutant was co-transfected in HEK 293T cells together with a truncated
chain and Iip35 LI/ML, we were able to detect cell-surface expression of the invariant chain. However, the surface over total Ii ratio showed that, in comparison to the wild-type DRß chain, DRß R was less potent. The fact that a single Arg residue somehow overcomes the Iip35 ER retention motif strongly argues against a model where the DRß chain operates through steric hindrance masking.
|
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Although RXR or KKXX ER retention motifs have been described in several oligomeric proteins, the mechanisms by which they are masked remain ill defined. In the case of the human high-affinity receptor for IgE (FcRI), Letourneur and Cosson have shown that, upon formation of the complex in the ER, the cytoplasmic tail of the
subunit masks the
chain dilysine motif (Letourneur et al., 1995
). Using various chimeric constructs and reporter molecules, they demonstrated that any cytoplasmic domain longer than 15 amino acids on the
subunit successfully hides the
chain KK motif and allows plasma-membrane expression. These results led to the conclusion that the masking is caused by steric hindrance following juxtaposition of the two cytoplasmic regions.
In the case of DRß, we showed that the presence of only three cytoplasmic amino acids, the nature of which does not appear to be crucial, allows ER egress of Iip35. For three main reasons, these data are difficult to reconcile with a trivial steric hindrance mechanism in which DR prevents access of COPI to the Iip35 cytoplasmic tail. First, the RXR motif is located 41 residues away from the Ii transmembrane-cytoplasmic domain junction and would probably not be close enough to the membrane to be influenced by a three-amino-acids tail. Second, it would be difficult to ascribe steric masking properties to a three-residue DRß tail given that the closely juxtaposed DR cytoplasmic tail, comprising 15 amino acids with complex side chains, does not impinge on ER retention. Finally, even the full-length DRß cytoplasmic tail does not overcome ER retention in the presence of an unphosphorylated Iip35.
Other recent studies have proposed the existence of key amino-acid sequences capable of overcoming RXR motifs on binding partners. Results on the NMDA receptor showed that a cytoplasmic four-amino-acid stretch next to the membrane in NR2 regulates the export of associated RXR-bearing NR1 subunits. Because site-directed mutagenesis in this NR2 motif abrogated the activity, the results suggested that certain amino-acid sequences could allow ER egress independently of their capacity sterically to mask retention signals (Hawkins et al., 2004). Very similar results were obtained using the kainate receptor GluR6a and GluR5c subunits (Jaskolski et al., 2004
). The mechanisms of action of such `release' motifs have not yet been characterized. For Ii, the need for a precise DRß amino acid sequence suggests that facilitation of ER export is mediated by a mechanism different from those involving, for example, DXE or FCYENE motifs (Nishimura and Balch, 1997
; Ma et al., 2001
).
In addition to dominant trans-acting motifs, it was reported that cis-acting sequences can play a role in the inactivation of RXR retention signals. Although the ligand is unknown, a PDZ-binding domain in an alternatively spliced NR1 isoform was shown to inactivate the closely positioned RXR retention motif upstream in the cytoplasmic region (Scott et al., 2001). Also, protein-kinase-C phosphorylation of serine residues next to the RXR motif in the NR1 subunit of the NMDA receptor was suggested to promote ER egress (Scott et al., 2001
). O'Kelly and collaborators recently suggested the existence of a cis-acting release motif on Iip35 (O'Kelly et al., 2002
). It was postulated that the binding of 14-3-3 proteins to the phosphorylated Ser8 would prevent the interaction with ß-COP and allow ER egress. Although its exact role remains obscure, Ser8 is clearly part of a release motif because its mutation to alanine prevents egress even in the presence of wild-type HLA-DR (Kuwana et al., 1998
). In light of our results, it is possible that the membrane-lining residues in the class II ß-chain cytoplasmic tail also represent a release motif or domain.
The YFR sequence of DRß is replaced by HRR in DPß and HHR in DQß, two other isotypes that overcome the retention motif of Iip35. Despite the presence of a conserved Arg, our mutagenesis results suggest that this residue is not crucial. Interestingly, a single Arg residue at the C-terminus of a truncated chain (Fig. 5, ß R) can somehow overcome the retention motif. The possibility remains that this Arg residue corrects a defect in the membrane insertion of the DR ßTM chain with no positively charged residue at its C-terminal end. However, the fully truncated DR TM-ßTM heterodimer is found at the cell surface in the absence of Iip35, suggesting that its conformation is adequate (Khalil et al., 2003
). Also, the DR ßYAA does not include any charged cytoplasmic residue and efficiently overcomes the RXR motif of Iip35 (Fig. 4). Rather, the arginine might `snorkel' and position its long apolar side chain through the hydrocarbon region of the membrane to expose only its polar extremity to the interfacial region (Killian and von Heijne, 2000
). This would artificially extend the transmembrane region and could be in line with a steric effect. Although we propose that DR does not mask the RXR motif directly by steric hindrance, we cannot rule out the possibility that the ß chain cytoplasmic tail imposes structural constraints on the folding of the Ii cytoplasmic tail. The DR ßYFR residues are found at the membrane-water interfacial region and this location could determine their precise orientation (Granseth et al., 2005
). The class-II and Ii molecules interact in their lumenal part but also at the level of their transmembrane regions (Castellino et al., 2001
; Ashman and Miller, 1999
). Owing to such close proximity in the nonameric complex, it is possible that the three membrane-proximal DRß residues (YFR) affect the whole Ii cytoplasmic region and indirectly bring the RXR motif near the membrane, out of reach for COPI. Indeed, a recent study has defined a functional zone for the RXR motif based on its distance to the membrane (Shikano and Li, 2003
). Our results for Ii confirm that the RXR motif is inactive when too close to the membrane (Fig. 7). In the GABAB1 subunit, removal of the RSRR motif from its active zone by the interaction with the B2 subunit was recently proposed as a possible mechanism explaining ER egress of the receptor (Gassmann et al., 2005).
The interplay between the functional regions of Ii and the class-II ß cytoplasmic tail remains to be characterized. Although very small, the three-amino-acid cytoplasmic tail of DRß acquires functional properties, in contrast to the fully truncated version with only the tyrosine residue. The lateral diffusion properties of the two molecules in the membrane could be drastically different and might influence the behaviour of Ii (Capps et al., 2004). However, before one can understand the role of the DRß chain, the means and chaperones involved in Iip35 retention will need to be identified. Despite phosphorylation of Ser8 and 14-3-3 protein binding, Iip35 accumulates in the ER in the absence of class-II molecules. If one accepts that 14-3-3 proteins bind to Ii at the ER level and thus prevent the interaction with ß-COP (O'Kelly et al., 2002
) then a second ER-retention mechanism must prevail in the absence of class-II molecules. A COPI-independent mechanism has been proposed to explain the retrograde transport of toxins and glycosyltransferases in the presence of COPI inhibitors (Girod et al., 1999
; White et al., 1999
). However, we cannot exclude the possibility that, in the absence of class II, the 14-3-3-associated Ii trimer never leaves the ER and is rather retained by dynamic clustering and exclusion from exit sites, as described for Tapasin (Andersson et al., 1999
; Pentcheva et al., 2002
). Such retention would probably not be mediated by 14-3-3 proteins, because Schwappach and co-workers recently showed that a chimeric CD4 fused to a high-affinity 14-3-3-interacting peptide was not retained in the ER (Yuan et al., 2003
). There is no evidence so far for the existence of any COPI-independent mechanism of ER retention in the case of Ii. The role of class-II molecules in preventing such retention is thus impossible to predict. Anyhow, the idea that 14-3-3 proteins shield the RXR motif is difficult to reconcile with the fact that mutation of the phosphorylated residue Ser8 to aspartic acid (Iip35 S8D) prevents 14-3-3 protein binding but allows ER egress if class-II molecules are present (Kuwana et al., 1998
).
In conclusion, the mechanism by which the DRß chain overcomes the ER retention motif of Iip35 remains obscure. Many issues, such as the importance of stoichiometry, the sequence of events in the binding of chaperones, the role of Ii phosphorylation and the exact intracellular trafficking of the p35 isoform, must be tackled before a comprehensive model of class-II maturation can be proposed.
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Anderson, H. A. and Roche, P. A. (1998). Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments. J. Immunol. 160, 4850-4858.
Anderson, H. A., Bergstralh, D. T., Kawamura, T., Blauvelt, A. and Roche, P. A. (1999). Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments. J. Immunol. 163, 5435-5443.
Anderson, M. S. and Miller, J. (1992). Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 89, 2282-2286.
Anderson, M. S., Swier, K., Arneson, L. and Miller, J. (1993). Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal. J. Exp. Med. 178, 1959-1969.
Andersson, H., Kappeler, F. and Hauri, H. P. (1999). Protein targeting to endoplasmic reticulum by dilysine signals involves direct retention in addition to retrieval. J. Biol. Chem. 274, 15080-15084.
Ashman, J. B. and Miller, J. (1999). A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain. J. Immunol. 163, 2704-2712.
Bakke, O. and Dobberstein, B. (1990). MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63, 707-716.[CrossRef][Medline]
Bichet, D., Cornet, V., Geib, S., Carlier, E., Volsen, S., Hoshi, T., Mori, Y. and De Waard, M. (2000). The I-II loop of the Ca2+ channel alpha1 subunit contains an endoplasmic reticulum retention signal antagonized by the beta subunit. Neuron 25, 177-190.[CrossRef][Medline]
Bowie, J. U. (2005). Cell biology: border crossing. Nature 433, 367-369.[CrossRef][Medline]
Brunet, A., Samaan, A., Deshaies, F., Kindt, T. J. and Thibodeau, J. (2000). Functional characterization of a lysosomal sorting motif in the cytoplasmic tail of HLA-DOß. J. Biol. Chem. 275, 37062-37071.
Busch, R., Cloutier, I., Sekaly, R.-P. and Hammerling, G. J. (1996). Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15, 418-428.[Abstract]
Capps, G. G., Pine, S., Edidin, M. and Zuniga, M. C. (2004). Short class I major histocompatibility complex cytoplasmic tails differing in charge detect arbiters of lateral diffusion in the plasma membrane. Biophys. J. 86, 2896-2909.
Castellino, F., Han, R. and Germain, R. N. (2001). The transmembrane segment of invariant chain mediates binding to MHC class II molecules in a CLIP-independent manner. Eur. J. Immunol. 31, 841-850.[CrossRef][Medline]
Cosson, P. and Letourneur, F. (1994). Coatomer interaction with di-lysine endoplasmic reticulum retention motifs. Science 263, 1629-1631.[Medline]
Cresswell, P. (1994). Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12, 259-293.[CrossRef][Medline]
Deshaies, F., Brunet, A., Diallo, D. A., Denzin, L. K., Samaan, A. and Thibodeau, J. (2005). A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM. Proc. Natl. Acad. Sci. USA 102, 6443-6448.
Ericson, M. L., Sundstrom, M., Sansom, D. M. and Charron, D. J. (1994). Mutually exclusive binding of peptide and invariant chain to major histocompatibility complex class II antigens. J. Biol. Chem. 269, 26531-26538.
Gassmann, M., Haller, C., Stoll, Y., Abdel, A. S., Biermann, B., Mosbacher, J., Kaupmann, K. and Bettler, B. The RXR-type ER-retention/retrieval signal of GABAB1 requires distant spacing from the membrane to function. Mol. Pharmacol. 68, 137-144.
Girod, A., Storrie, B., Simpson, J. C., Johannes, L., Goud, B., Roberts, L. M., Lord, J. M., Nilsson, T. and Pepperkok, R. (1999). Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum. Nat. Cell Biol. 1, 423-430.[CrossRef][Medline]
Granseth, E., von Heijne, G. and Elofsson, A. (2005). A study of the membrane-water interface region of membrane proteins. J. Mol. Biol. 346, 377-385.[CrossRef][Medline]
Hawkins, L. M., Prybylowski, K., Chang, K., Moussan, C., Stephenson, F. A. and Wenthold, R. J. (2004). Export from the endoplasmic reticulum of assembled N-methyl-D-aspartic acid receptors is controlled by a motif in the D terminus of the NR2 subunit. J. Biol. Chem. 279, 28903-28910.
Hitzel, C. and Koch, N. (1996). The invariant chain derived fragment CLIP is an efficient in vitro inhibitor of peptide binding to MHC class II molecules. Mol. Immunol. 33, 25-31.[CrossRef][Medline]
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. and Pease, L. R. (1989). Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59.[CrossRef][Medline]
Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K. and Pease, L. R. (1989). Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77, 61-68.[CrossRef][Medline]
Jackson, M. R., Nilsson, T. and Peterson, P. A. (1990). Identification of a consensus motif for the retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9, 3153-3162.[Abstract]
Jaskolski, F., Coussen, F., Nagarajan, N., Normand, E., Rosenmund, C. and Mulle, C. (2004). Subunit composition and alternative splicing regulate membrane delivery of kainate receptors. J. Neurosci. 24, 2506-2515.
Jensen, P. E., Weber, D. A., Thayer, W. P., Westerman, L. E. and Dao, C. T. (1999). Peptide exchange in MHC molecules. Immunol. Rev. 172, 229-238.[Medline]
Khalil, H., Brunet, A., Saba, I., Terra, R., Sekaly, R. P. and Thibodeau, J. (2003). The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal. Int. Immunol. 15, 1249-1263.
Killian, J. A. and von Heijne, G. (2000). How proteins adapt to a membrane-water interface. Trends Biochem. Sci. 25, 429-434.[CrossRef][Medline]
Kuwana, T., Peterson, P. A. and Karlsson, L. (1998). Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation. Proc. Natl. Acad. Sci. USA 95, 1056-1061.
Lamb, C. A. and Cresswell, P. (1992). Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol. 148, 3478-3482.
Letourneur, F., Hennecke, S., Demolliere, C. and Cosson, P. (1995). Steric masking of a dilysine endoplasmic reticulum retention motif during assembly of the human high affinity receptor for immunoglobulin E. J. Cell Biol. 129, 971-978.[Abstract]
Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S. L., Quaranta, V. and Peterson, P. A. (1990). Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348, 600-605.[CrossRef][Medline]
Ma, D., Zerangue, N., Lin, Y. F., Collins, A., Yu, M., Jan, Y. N. and Jan, L. Y. (2001). Role of ER export signals in controlling surface potassium channel numbers. Science 291, 316-319.
Margeta-Mitrovic, M., Jan, Y. N. and Jan, L. Y. (2000). A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27, 97-106.[CrossRef][Medline]
Marks, M. S., Blum, J. S. and Cresswell, P. (1990). Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J. Cell Biol. 111, 839-855.[Abstract]
Motta, A., Bremnes, B., Morelli, M. A., Frank, R. W., Saviano, G. and Bakke, O. (1995). Structure-activity relationship of the leucine-based sorting motifs in the cytosolic tail of the major histocompatibility complex-associated invariant chain. J. Biol. Chem. 270, 27165-27171.
Motta, A., Amodeo, P., Fucile, P., Castiglione Morelli, M., Bremnes, B. and Bakke, O. (1997). A new triple-stranded -helical bundle in solution: the assembling of the cytosolic tail of MHC associated invariant chain. Structure 5, 1453-1464.[CrossRef][Medline]
Muslin, A. J. and Xing, H. (2000). 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal. 12, 703-709.[CrossRef][Medline]
Nijenhuis, M., Calafat, J., Kuijpers, K. C., Janssen, H., de Haas, M., Nordeng, T. W., Bakke, O. and Neefjes, J. J. (1994). Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling. Eur. J. Immunol. 24, 873-883.[Medline]
Nishimura, N. and Balch, W. E. (1997). A di-acidic signal required for selective export from the endoplasmic reticulum. Science 277, 556-558.
O'Kelly, I., Butler, M. H., Zilberberg, N. and Goldstein, S. A. (2002). Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell 111, 577-588.[CrossRef][Medline]
O'Sullivan, D. M., Noonan, D. and Quaranta, V. (1987). Four Ia invariant chain forms derive from a single gene by alternative splicing and alternate initiation of transcription/translation. J. Exp. Med. 166, 444-450.
Odorizzi, C. G., Trowbridge, I. S., Xue, L., Hopkins, C. R., Davis, C. D. and Collawn, J. F. (1994). Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J. Cell Biol. 126, 317-330.[Abstract]
Pelham, H. R. (1995). Sorting and retrieval between the endoplasmic reticulum and Golgi apparatus. Curr. Opin. Cell Biol. 7, 530-535.[CrossRef][Medline]
Pentcheva, T., Spiliotis, E. T. and Edidin, M. (2002). Cutting edge: Tapasin is retained in the endoplasmic reticulum by dynamic clustering and exclusion from endoplasmic reticulum exit sites. J. Immunol. 168, 1538-1541.
Pieters, J., Bakke, O. and Dobberstein, B. (1993). The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J. Cell. Sci. 106, 831-846.
Robadey, C., Ammerlaan, W., Muller, C., Cloutier, I., Sékaly, R. P., Haefliger, J. A. and Demotz, S. (1997). The processing routes determined by negatively charged residues in DR1-restricted T cell determinants. J. Immunol. 159, 3238-3246.[Abstract]
Roche, P. A. and Cresswell, P. (1990). Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345, 615-618.[CrossRef][Medline]
Roche, P. A., Marks, M. S. and Cresswell, P. (1991). Identification of the HLA class II-invariant chain complex as a nine subunit transmembrane glycoprotein. Nature 354, 392-394.[CrossRef][Medline]
Roche, P. A., Teletski, C. L., Karp, D. R., Pinet, V., Bakke, O. and Long, E. O. (1992). Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO J. 11, 2841-2847.[Abstract]
Roche, P. A., Teletski, C. L., Stang, E., Bakke, O. and Long, E. O. (1993). Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc. Natl. Acad. Sci. USA 90, 8581-8585.
Romagnoli, P. and Germain, R. N. (1994). The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med. 180, 1107-1113.
Schutze, M.-P., Peterson, P. A. and Jackson, M. R. (1994). An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum. EMBO J. 13, 1696-1705.[Abstract]
Scott, D. B., Blanpied, T. A., Swanson, G. T., Zhang, C. and Ehlers, M. D. (2001). An NMDA receptor ER retention signal regulated by phosphorylation and alternative splicing. J. Neurosci. 21, 3063-3072.
Sekaly, R.-P., Tonnelle, C., Strubin, M., Mach, B. and Long, E. O. (1986). Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain. J. Exp. Med. 164, 1490-1504.
Shikano, S. and Li, M. (2003). Membrane receptor trafficking: evidence of proximal and distal zones conferred by two independent endoplasmic reticulum localization signals. Proc. Natl. Acad. Sci. USA 100, 5783-5788.
Standley, S., Roche, K. W., McCallum, J., Sans, N. and Wenthold, R. J. (2000). PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron 28, 887-898.[CrossRef][Medline]
Strubin, M., Long, E. O. and Mach, B. (1986). Two forms of the Ia antigen-associated invariant chain result from alternative initiations at two in-phase AUGs. Cell 47, 619-625.[CrossRef][Medline]
Stumptner, P. and Benaroch, P. (1997). Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region. EMBO J. 16, 5807-5818.
Teyton, L., O'Sullivan, D., Dickson, P. W., Lotteau, V., Sette, A., Fink, P. and Peterson, P. A. (1990). Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348, 39-44.[CrossRef][Medline]
Thery, C., Brachet, V., Regnault, A., Rescigno, M., Ricciardi-Castagnoli, P., Bonnerot, C. and Amigorena, S. (1998). MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains. J. Immunol. 161, 2106-2113.
Tonnelle, C., DeMars, R. and Long, E. O. (1985). DOß: a new ß chain gene in HLA-D with a distinct regulation of expression. EMBO J. 4, 2839-2847.[Abstract]
Tzivion, G., Shen, Y. H. and Zhu, J. (2001). 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20, 6331-6338.[CrossRef][Medline]
van Hemert, M. J., Steensma, H. Y. and van Heusden, G. P. (2001). 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. BioEssays 23, 936-946.[CrossRef][Medline]
Warmerdam, P. A., Long, E. O. and Roche, P. A. (1996). Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments. J. Cell Biol. 133, 281-291.[Abstract]
Watanabe, M., Suzuki, T., Taniguchi, M. and Shinohara, N. (1983). Monoclonal anti-Ia murine alloantibodies crossreactive with the Iahomologues of other mammalian species including humans. Transplantation 36, 712-718.[Medline]
White, J., Johannes, L., Mallard, F., Girod, A., Grill, S., Reinsch, S., Keller, P., Tzschaschel, B., Echard, A., Goud, B. et al. (1999). Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells. J. Cell Biol. 147, 743-760.
Wraight, C. J., Van Endert, P., Moller, P., Lipp, J., Ling, N. R., MacLennan, I. C., Koch, N. and Moldenhauer, G. (1990). Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J. Biol. Chem. 265, 5787-5792.
Yaffe, M. B. (2002). How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513, 53-57.[CrossRef][Medline]
Yuan, H., Michelsen, K. and Schwappach, B. (2003). 14-3-3 dimers probe the assembly status of multimeric membrane proteins. Curr. Biol. 13, 638-646.[CrossRef][Medline]
Zerangue, N., Schwappach, B., Jan, Y. N. and Jan, L. Y. (1999). A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 22, 537-548.[CrossRef][Medline]
|